These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6162773)

  • 1. Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia.
    Ree HJ; Song JY; Leone LA; Crowley JP; Fanger H
    Hum Pathol; 1981 Jan; 12(1):49-59. PubMed ID: 6162773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cell adhesion molecules associated with germinal center in Hodgkin's disease: an immunohistochemical study. The germinal center related complex and histologic subtypes.
    Ree HJ; Khan AA; Qureshi MN; Teplitz C
    Cancer; 1994 Feb; 73(4):1257-63. PubMed ID: 7906194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
    Miettinen M; Franssila KO; Saxén E
    Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-histiocyte lysozyme activity in relation to the clinical presentation of Hodgkin's disease. An immunohistochemical study.
    Ree HJ; Crowley JP; Leone LA
    Cancer; 1981 Apr; 47(8):1988-93. PubMed ID: 6164477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of histiocytic reticulum cells in diffuse and follicular non-Hodgkin's lymphomas.
    Crocker J; Jenkins R
    J Clin Pathol; 1984 Nov; 37(11):1222-6. PubMed ID: 6389602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ammoniacal silver staining of lymph node cells. I. its potential value for the diagnosis of Hodgkin's disease.
    Rengifo E; Quintero S; Marinello Z
    Neoplasma; 1983; 30(4):469-73. PubMed ID: 6193436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
    Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
    J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammoniacal silver staining of lymph node cells. II. Reactive follicular hyperplasia and its relationship with Hodgkin's disease.
    Rengifo E; Quintero S; Marinello Z
    Neoplasma; 1985; 32(6):741-4. PubMed ID: 2418374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular dendritic cells in Hodgkin's disease.
    Alavaikko MJ; Hansmann ML; Nebendahl C; Parwaresch MR; Lennert K
    Am J Clin Pathol; 1991 Feb; 95(2):194-200. PubMed ID: 1992609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
    Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
    Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin staining of carbohydrates of haemic cells. III. The cells of Hodgkin's disease and other lymphomas.
    Collins RD; Jacobson W; Stoddart RW
    Histopathology; 1982 Sep; 6(5):601-16. PubMed ID: 6183188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.
    Shimizu K; Hara K; Kunii A
    Am J Clin Pathol; 1986 Sep; 86(3):370-4. PubMed ID: 3529930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
    Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
    Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cell counts in the histiocytic variant of lymphocytic predominance subtype of Hodgkin's disease.
    Sutherland FI; MacGillivray JB; Brown RA; Beck JS
    J Clin Pathol; 1978 Dec; 31(12):1234-8. PubMed ID: 748394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
    Pinkus GS; Said JW
    Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.